BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]

Larsen S, Butthongkomvog K, Manikhas A, et al. Breast Cancer: Targets and Therapy. 2014;6:179–189.On page 184 there is an error in Figure 3A. The error consists of a yellow bar at +16 days in the placebo group. Read the original article

Guardado en:

Detalles Bibliográficos
Autores principales:	Larsen S, Butthongkomvong K, Manikhas A, Trishkina E, Poddubuskaya E, Matrosova M, Srimuninnimit V, Lindkær-Jensen S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/944f9e6b8bb04a3583a2cd6514f4fbcb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:944f9e6b8bb04a3583a2cd6514f4fbcb
record_format	dspace
spelling	oai:doaj.org-article:944f9e6b8bb04a3583a2cd6514f4fbcb2021-12-02T05:00:13ZBP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]1179-1314https://doaj.org/article/944f9e6b8bb04a3583a2cd6514f4fbcb2015-06-01T00:00:00Zhttp://www.dovepress.com/corrigendum-bp-c1-in-the-treatment-of-patients-with-stage-iv-bre-peer-reviewed-article-BCTThttps://doaj.org/toc/1179-1314Larsen S, Butthongkomvog K, Manikhas A, et al. Breast Cancer: Targets and Therapy. 2014;6:179–189.On page 184 there is an error in Figure 3A. The error consists of a yellow bar at +16 days in the placebo group. Read the original articleLarsen SButthongkomvong KManikhas ATrishkina EPoddubuskaya EMatrosova MSrimuninnimit VLindkær-Jensen SDove Medical PressarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol 2015, Iss default, Pp 163-164 (2015)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Larsen S Butthongkomvong K Manikhas A Trishkina E Poddubuskaya E Matrosova M Srimuninnimit V Lindkær-Jensen S BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]
description	Larsen S, Butthongkomvog K, Manikhas A, et al. Breast Cancer: Targets and Therapy. 2014;6:179–189.On page 184 there is an error in Figure 3A. The error consists of a yellow bar at +16 days in the placebo group. Read the original article
format	article
author	Larsen S Butthongkomvong K Manikhas A Trishkina E Poddubuskaya E Matrosova M Srimuninnimit V Lindkær-Jensen S
author_facet	Larsen S Butthongkomvong K Manikhas A Trishkina E Poddubuskaya E Matrosova M Srimuninnimit V Lindkær-Jensen S
author_sort	Larsen S
title	BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]
title_short	BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]
title_full	BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]
title_fullStr	BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]
title_full_unstemmed	BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]
title_sort	bp-c1 in the treatment of patients with stage iv breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [corrigendum]
publisher	Dove Medical Press
publishDate	2015
url	https://doaj.org/article/944f9e6b8bb04a3583a2cd6514f4fbcb
work_keys_str_mv	AT larsens bpc1inthetreatmentofpatientswithstageivbreastcancerarandomizeddoubleblindplacebocontrolledmulticenterstudyandanadditionalopenlabeltreatmentphasecorrigendum AT butthongkomvongk bpc1inthetreatmentofpatientswithstageivbreastcancerarandomizeddoubleblindplacebocontrolledmulticenterstudyandanadditionalopenlabeltreatmentphasecorrigendum AT manikhasa bpc1inthetreatmentofpatientswithstageivbreastcancerarandomizeddoubleblindplacebocontrolledmulticenterstudyandanadditionalopenlabeltreatmentphasecorrigendum AT trishkinae bpc1inthetreatmentofpatientswithstageivbreastcancerarandomizeddoubleblindplacebocontrolledmulticenterstudyandanadditionalopenlabeltreatmentphasecorrigendum AT poddubuskayae bpc1inthetreatmentofpatientswithstageivbreastcancerarandomizeddoubleblindplacebocontrolledmulticenterstudyandanadditionalopenlabeltreatmentphasecorrigendum AT matrosovam bpc1inthetreatmentofpatientswithstageivbreastcancerarandomizeddoubleblindplacebocontrolledmulticenterstudyandanadditionalopenlabeltreatmentphasecorrigendum AT srimuninnimitv bpc1inthetreatmentofpatientswithstageivbreastcancerarandomizeddoubleblindplacebocontrolledmulticenterstudyandanadditionalopenlabeltreatmentphasecorrigendum AT lindkaeligrjensens bpc1inthetreatmentofpatientswithstageivbreastcancerarandomizeddoubleblindplacebocontrolledmulticenterstudyandanadditionalopenlabeltreatmentphasecorrigendum
_version_	1718400842369859584

BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]

Ejemplares similares